Asthma Plagued By Myths, Stigma, & Lack Of Information: Dr Vikas Gupta

In an interaction with BW Healthcare World, Dr Vikas Gupta, India Business Rx Head, Cipla speaks on the causes of the increasing asthma burden of India, its solutions, stigmas, challenges and awareness and management of the disease

Q2 Results: Cipla Registers 5.7% Rise In Revenue, Reports PAT At Rs 789 Cr

The pharmaceutical company’s net profit also jumped by 10.91 per cent quarter on quarter in Q2FY22, the company recorded a net profit of Rs 788.90 crores in the September quarter

HC Allows Sun Pharmaceuticals To Use Word 'Respules' In Interim Order

Passing interim orders, the judge said the evidence on record indicates prima facie that the word 'Respules' is used both by other manufacturers and by authorities such as the Director General of Health Services and the Drug Controller

Cipla Invests Rs 26 crore In GoApptiv For Raising Stake To 22 pc

Pharma company Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said on Monday

Cipla To Acquire 21 Pc Stake In Achira Labs

Pharma major Cipla Ltd on Friday said it will acquire 21.05 per cent stake for Rs 25 crore in Achira Labs Pvt Ltd, which is engaged in development and commercialisation of point of care (PoC) medical test kits in India. The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing

Cipla Prices Its Generic Remdesivir At $53.34 Per Vial, Below Rivals

Privately held Hetero Labs Ltd's version, Covifor, costs 5,400 rupees per vial while Mylan prices Desrem at 4,800 rupees.

Cipla Sets Up Rs 25 Crore COVID-19 Dedicated Fund

The company has also allocated Rs 4 crore towards the supply of essentials including medicines, personal protective equipment, sanitisers, masks, gloves and food.

Cipla Health Limited Partners With Zomato, Swiggy And Dunzo To Provide Essential Wellness Offerings To Its Consumers

The delivery protocol strictly adheres to the hygiene and safety guidelines provided by the government authorities

Week Ahead: Shares To Track GDP, Foreign Inflows

Cipla Q4 Net Drops 8.2%, Lags Estimates

Top Medpro Shareholder Aays Cipla Should Raise Offer

Cipla Q3 Net Up 25.5%, Slightly Misses Estimates

Sensex Down 6th Day, Biggest Losing Streak Since Nov '11

BSE Sensex Ends Higher; ITC, SBI Gain

India Revokes Patent On Merck Asthma Drug